Dehydroepiandrosterone Administration in Treating Medical and Neuropsychiatric Disorders-Reference-Cited by-同舟云学术

Dehydroepiandrosterone Administration in Treating Medical and Neuropsychiatric Disorders

Published:2008 Issue: Volume: Page:337-368
ISSN:
Container-title:Neuroactive Steroids in Brain Function, Behavior and Neuropsychiatric Disorders
language:
Short-container-title:

Author:

Ritsner Michael S.

Publisher

Springer Netherlands

Link

http://link.springer.com/content/pdf/10.1007/978-1-4020-6854-6_17.pdf

Reference132 articles.

1. Young J, Couzinet B, Nahoul K, et al. Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans. J Clin Endocrinol Metab 1997; 82:2578–2585.

2. Morales AJ, Haubrich RH, Hwang JY, et al. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol (Oxf) 1998; 49:421–432.

3. Casson PR, Santoro N, Elkind-Hirsch K, et al. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial. Fertil Steril 1998; 70:107–110.

4. Arlt W, Justl HG, Callies F, et al. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab 1998; 83:1928–1934.

5. Arlt W, Callies F, van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999; 341:1013–1020.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical and therapeutic potentials of dehydroepiandrosterone and pregnenolone in schizophrenia;Neuroscience;2011-09

2. Pregnenolone, Dehydroepiandrosterone, and Schizophrenia: Alterations and Clinical Trials;CNS Neuroscience & Therapeutics;2010-02

3. Is a Neuroprotective Therapy Suitable for Schizophrenia Patients?;Brain Protection in Schizophrenia, Mood and Cognitive Disorders;2010